AssetMark Inc’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6
Closed 1390
2019
Q1
$0 Hold
6
﹤0.01% 1449
2018
Q4
$0 Hold
6
﹤0.01% 1497
2018
Q3
$0 Hold
6
﹤0.01% 1438
2018
Q2
$0 Hold
6
﹤0.01% 1437
2018
Q1
$0 Hold
6
﹤0.01% 1718
2017
Q4
$0 Hold
6
﹤0.01% 2006
2017
Q3
$0 Sell
6
-34
-85% -$448 ﹤0.01% 1552
2017
Q2
$1K Buy
40
+34
+567% +$473 ﹤0.01% 1311
2017
Q1
$0 Hold
6
﹤0.01% 1367
2016
Q4
$0 Hold
6
﹤0.01% 1326
2016
Q3
$0 Hold
6
﹤0.01% 1245
2016
Q2
$0 Hold
6
﹤0.01% 1233
2016
Q1
$0 Hold
6
﹤0.01% 1309
2015
Q4
$0 Sell
6
-24,404
-100% -$300K ﹤0.01% 1436
2015
Q3
$285K Sell
24,410
-41,672
-63% -$552K 0.01% 306
2015
Q2
$954K Sell
66,082
-2,828
-4% -$40.8K 0.02% 297
2015
Q1
$961K Sell
68,910
-2,480
-3% -$34.3K 0.02% 282
2014
Q4
$986K Sell
71,390
-3,474
-5% -$44.9K 0.02% 282
2014
Q3
$917K Sell
74,864
-3,878
-5% -$48.4K 0.02% 298
2014
Q2
$983K Buy
78,742
+5,287
+7% +$62.2K 0.02% 295
2014
Q1
$820K Buy
73,455
+22,533
+44% +$247K 0.02% 267
2013
Q4
$617K Buy
50,922
+4,277
+9% +$51.1K 0.01% 311
2013
Q3
$569K Buy
+46,645
New +$651K 0.01% 311

Other funds holding LFCR

AssetMark Inc's LFCR Position: Q2 2019 in Review

AssetMark Inc sold out of Lifecore Biomedical (LFCR) in Q2 2019, closing a stake of 6 shares.

AssetMark Inc first reported a position in LFCR in Q3 2013 and held it in 23 quarters. The position peaked at $986K in Q4 2014. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2019.

  • AssetMark Inc reported no remaining Lifecore Biomedical position as of Q2 2019 after selling out during the quarter.
  • AssetMark Inc sold 6 Lifecore Biomedical shares in Q2 2019.
  • AssetMark Inc first reported a position in Lifecore Biomedical in Q3 2013 and held it in 23 quarters.
  • AssetMark Inc's Lifecore Biomedical position peaked at $986K in Q4 2014.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2019.

Based on AssetMark Inc's 13F filing for Q2 2019, filed 14 Aug 2019.